Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indiplon with Sertraline for Insomnia and Depression
NCT00232167Phase 3Terminated
- Sponsor
- Neurocrine Biosciences
- Start
- Nov 2005
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial in Insomnia comparing Indiplon + Sertraline with Placebo + Sertraline (2 arms). Primary endpoint: Subjective Total Sleep Time at 1 week. Started Nov 2005; status: terminated.
02
Drugs
Indiplon
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00232167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00232167.